Kathleen M Sakamoto, MD
Pediatric Hematology-Oncology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sakamoto’s office at (650) 497-8000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence G58328 · Current
Licensed to practise in California · since 1986 · expires 2027-12-31 · University of Cincinnati College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatric Hematology-Oncology
- American Board of Pediatrics - Pediatrics
Medicaid work
$5,334 in 2023
Medicaid paid $5,334 for 71 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 57 | $3,457 |
| Long return visit (40+ min) | 14 | $1,877 |
| 2023 | 71 | 2 | 13 | $5,334 |
| 2022 | 95 | 1 | 14 | $7,765 |
| 2019 | 109 | 1 | 15 | $8,678 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 95 | $7,765 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 109 | $8,678 |
Money from drug and device companies
$1,150 in 2024
| 2024 | 2 | 2 | $1,000 | $1,150 |
| 2023 | 3 | 4 | $2,625 | $2,781 |
| 2022 | 1 | 2 | $2,750 | $2,750 |
| 2021 | 2 | 2 | $1,750 | $2,388 |
| 2020 | 1 | 2 | $2,000 | $2,000 |
| 2019 | 2 | 2 | $500 | $553 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Kyprolis | $1,000 | 1 payment
|
| Jazz Pharmaceuticals | Rylaze | $150 | 1 payment
|
See all 2 published payments
| Jazz Pharmaceuticals | Meals · 2024-10-20 | Rylaze | $150 |
| Amgen | Consulting · 2024-03-15 | Kyprolis | $1,000 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $2,781
| Amgen | Kyprolis | $2,625 | 2 payments
|
| Sobi | Gamifant | $114 | 1 payment
|
| Jazz Pharmaceuticals | Rylaze | $41 | 1 payment
|
2022: $2,750
| Amgen | Kyprolis | $2,750 | 2 payments
|
2021: $2,388
| Amgen | Kyprolis | $1,750 | 1 payment
|
| Taiho Oncology | None | $638 | 1 payment
|
2020: $2,000
| Amgen | Kyprolis | $2,000 | 2 payments
|
2019: $553
| Amgen | Kyprolis | $500 | 1 payment
|
| Sobi | Gamifant | $53 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Acerta Pharma LLC · 2019 | Their institution | $33,208 |
| Acerta Pharma LLC · Part 1 Fl An Open Label Phase 1b Study of Acp196 Alone Or in Combination With Rituximab in Subjects With Follicular Lymphoma Part 2 Mzl An Open Label Phase 1b Or 2 Study of Acalabrutinib Alone Or in Combination With Rituximab in Subjects With Indolent Bcell Non Hodgkin Lymphoma · 2019 | Their institution | $32,920 |
Professional record
- NPI
- 1437268539
- Licence
- CA G58328California G58328: Current · expires 2027-12-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G583280, CA GR0053510
- Taxonomy
- Federal specialty code 2080P0207X (2080P0207X); Pediatrics (208000000X)
- Mailing address
- 1000 Welch Rd Ste 300, Palo Alto, CA, 94304
- NPI first listed
- 2006-08-30
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.